|
TMX1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.379200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.251600E-02 |
| Normal-vs-Stage2 |
5.366000E-01 |
| Normal-vs-Stage3 |
8.107600E-01 |
| Normal-vs-Stage4 |
4.237200E-01 |
| Stage1-vs-Stage2 |
2.100400E-01 |
| Stage1-vs-Stage3 |
2.078000E-02 |
| Stage1-vs-Stage4 |
2.237900E-04 |
| Stage2-vs-Stage3 |
6.709400E-01 |
| Stage2-vs-Stage4 |
2.076600E-01 |
| Stage3-vs-Stage4 |
2.940400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.212420E-01 |
| Normal-vs-AfricanAmerican |
5.447800E-01 |
| Normal-vs-Asian |
3.900400E-01 |
| Caucasian-vs-AfricanAmerican |
1.542110E-02 |
| Caucasian-vs-Asian |
7.944400E-01 |
| AfricanAmerican-vs-Asian |
1.898020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.696000E-01 |
| Normal-vs-Female |
1.914420E-01 |
| Male-vs-Female |
7.793600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.353800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.280170E-01 |
| Normal-vs-Age(61-80Yrs) |
2.665800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.369000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.159200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.225000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.122000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.272400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.523600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.480800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.735700E-03 |
| Normal-vs-Grade 2 |
7.962600E-03 |
| Normal-vs-Grade 3 |
6.400600E-01 |
| Normal-vs-Grade 4 |
1.172800E-01 |
| Grade 1-vs-Grade 2 |
1.254820E-01 |
| Grade 1-vs-Grade 3 |
9.639200E-03 |
| Grade 1-vs-Grade 4 |
3.605700E-04 |
| Grade 2-vs-Grade 3 |
3.476800E-03 |
| Grade 2-vs-Grade 4 |
1.51299999999743E-05 |
| Grade 3-vs-Grade 4 |
1.624220E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.620500E-04 |
| Normal-vs-ccB subtype |
9.498400E-01 |
| ccA subtype-vs-ccB subtype |
1.443990E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.402410E-01 |
| Normal-vs-N1 |
2.856400E-01 |
| N0-vs-N1 |
1.082550E-01 |
|
|
